NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Stem Cell Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Stem Cell Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Biomedical Engineering



Studies from Germany describe new findings in biomedical engineering research



August 14th, 2006

Investigators in Germany have published new biomedical engineering data.

Study 1: Collagen markers have been identified for chondrocyte dedifferentiation into a more fibroblastoid cell type.

"Tissue engineering is a promising method for the generation of chondrogenic grafts for reconstructive surgery. In cultured chondrocytes, the dedifferentiation of cells seems unavoidable for multiplication," investigators in Germany report.

According to scientists, "In this study, we investigated the expression of distinct markers during the dedifferentiation of human chondrocytes (HC) harvested during septoplasty and human mesenchymal stem...


Source: Stem Cell Week (2006-08-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login